发明名称 FORMULATION COMPRISING A GEMCITABINE-PRODRUG
摘要 This invention relates to pharmaceutical formulations of gemcitabine-[phenyl-benzoxy-L-alaninyl)]-phosphate, a monophosphate derivative of the well-known oncology drug gemcitabine. In particular, the invention relates to formulations which comprise a polar aprotic solvent, preferably dimethyl acetamide (DMA). Formulations comprising these solvent provide therapeutically effective treatments of gemcitabine-[phenyl-benzoxy-L-alaninyl)]-phosphate. The invention also relates to methods of using said formulations and kits comprising said formulations.
申请公布号 US2017095498(A1) 申请公布日期 2017.04.06
申请号 US201515308475 申请日期 2015.06.25
申请人 NuCana Biomed Limited 发明人 Griffith Hugh;Kennovin Gordon
分类号 A61K31/7068;A61K47/26;A61K47/18;A61K47/44;A61K9/00;A61K9/08 主分类号 A61K31/7068
代理机构 代理人
主权项 1. A pharmaceutical formulation comprising: gemcitabine[phenyl-benzoxy-L-alaninyl)]-phosphate; a polar aprotic solvent; and optionally one or more pharmaceutically acceptable excipients.
地址 Edinburgh GB